Lung function Improvement and Asthma Exacerbation Reduction with Indacaterol/Glycopyrronium/Mometasone Furoate in Uncontrolled Asthma: IRIDIUM Study

13 Jun 2020
Respiratory conditions
  • Asthma
Respiratory topics
  • Treatment - drug
  • Disease management
Type of resource
Abstract
Conference
2020 Virtual Conferences
Author(s)
Alberto Papi1, Marc Humbert2, Konstantinos Kostikas3, Christian Domingo4, Jorge F. Máspero5, Karen Mezzi6, Ivan Nikolaev6, Motoi Hosoe6, Ana-Maria Tanase6, Abhijit Pethe7, Xu Shu7, Peter D’Andrea7 1Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy, 2Université Paris-Saclay, Service de Pneumologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, Paris, France, 3Respiratory Medicine Department, University Hospital of Ioannina, Ioannina, Greece, 4Departament de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain, 5Allergy and Respiratory Research Unit, Fundacion CIDEA, Buenos Aires, Argentina, 6Novartis Pharma AG, Basel, Switzerland, 7Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States